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379 - “Use with caution in renal impairment” – 
implications for drug dosing in the general practice 
setting
Jordan M1, Stewart A1, Blaze J2, Hall J2, Frew H1, Mullan J3
1Woonona Medical Pratice, 2Bulli Medical Practice, 3School or Medicine, University of 
Wollongong 
Introduction: The number of medicines requiring attention in declining kidney function, 
and prescribed by GPs, is growing. A clinical pharmacist was integrated within a general 
practice, to investigate the management of anticoagulants. The results highlighted the 
implications of using readily available estimates (uncorrected Glomerular Filtration Rate, 
“eGFR”) for dosing of the non-vitamin K antagonist oral anticoagulants (NOACs) and 
informed a second project in a separate practice.
Aims: To describe how kidney function is assessed in two general practices, the 
implications on use of renally-excreted medicines and the impact of a pharmacist.
Methods: Two general practice research projects were undertaken. Study 1 investigated 
the impact of the pharmacist on the management of warfarin and NOACs, compared to 
the results from a retrospective review. Study 2 assessed appropriateness of medicine 
management in patients over 65 with impaired kidney function, before and after 
pharmacist input. Medicines most commonly prescribed were targeted. Estimates of 
kidney function were compared (eGFR and calculated creatinine clearance [eCrCl]) in 
both studies.
Results: Study 1: Prior to pharmacist input, eGFR was used to guide drug-dosing of 
NOACS: usage was appropriate for 50% patients compared to 100% at the study close 
(P = 0.0245). Study 2: The appropriateness of management of the target medicines 
(pregabalin, NOACS, antidiabetic agents, statins, digoxin) improved from 42% to 88% 
(P<0.0001) despite similarities in measures of kidney function (P=0.4872). The means of 
kidney function metrics (eGFR vs eCrCl) differed significantly from each other in both 
stages: 63mL/min/1.73m² vs 47mL/min; (P <0.001.)
Implications for practice change: Significant differences in the estimates of kidney 
function lead to discrepancies in drug dosing, particularly for the NOACs. GPs have an 
ever-increasing range of medicines to manage, with competing sources for guidance. 
The input of a clinical pharmacist can improve the management of medicines in kidney 
impairment in general practices. 
